| 2025-10-23 |
Oramed, Ltd. |
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives oramed.com ↗ |
| 2025-02-11 |
Oramed, Ltd. |
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin oramed.com ↗ |
| 2023-05-15 |
Oramed, Ltd. |
Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China oramed.com ↗ |
| 2022-11-29 |
Oramed, Ltd. |
Oramed Announces Publication of Oral Insulin Study in Peer-Reviewed Journal: Diabetes, Obesity, and Metabolism oramed.com ↗ |
| 2022-11-14 |
Oramed, Ltd. |
Oramed Signs Definitive Deal with Medicox to Commercialize Oral Insulin in South Korea oramed.com ↗ |
| 2022-09-13 |
Oramed, Ltd. |
Oramed Reports Positive Top-Line Results from Phase 2 NASH Trial with its ORMD-0801, Oral Insulin Candidate oramed.com ↗ |
| 2022-07-26 |
Oramed, Ltd. |
Oramed Reaches 50% Enrollment in its Second Phase 3 Oral Insulin Trial oramed.com ↗ |
| 2022-05-03 |
Oramed, Ltd. |
Oramed Completes Patient Enrollment in Pivotal Phase 3 Oral Insulin Study ORA-D-013-1 oramed.com ↗ |
| 2022-03-29 |
Oramed, Ltd. |
Oramed’s Diabetes Market Survey Shows Strong Interest for ORMD-0801 Oral Insulin Candidate Among Physicians oramed.com ↗ |
| 2022-03-22 |
Oramed, Ltd. |
Oramed to Host Key Opinion Leader Webinar on Need for Oral Insulin in Type 2 Diabetes oramed.com ↗ |
| 2022-03-16 |
Oramed, Ltd. |
Oramed Completes Patient Enrollment in Phase 2 Oral Insulin NASH Trial oramed.com ↗ |
| 2021-11-23 |
Oramed, Ltd. |
Oramed Reaches 75% Enrollment in Phase 3 Oral Insulin Study oramed.com ↗ |
| 2021-09-15 |
Oramed, Ltd. |
Oramed’s Phase 2 Oral Insulin NASH Trial Reaches Over 50% Enrollment oramed.com ↗ |
| 2021-08-24 |
Oramed, Ltd. |
Oramed Reaches 25% Enrollment in Its Second of Two Concurrent Phase 3 Oral Insulin Trials oramed.com ↗ |
| 2021-08-16 |
Oramed, Ltd. |
Oramed Announces Publication of Oral Insulin Study in Peer-Reviewed Journal: Diabetes, Obesity, and Metabolism oramed.com ↗ |
| 2021-06-08 |
Oramed, Ltd. |
Oramed Reaches 50% Enrollment in Phase 3 Oral Insulin Study oramed.com ↗ |
| 2021-05-25 |
Oramed, Ltd. |
Oramed Issues Letter to Shareholders with Updates on Oral Insulin and COVID-19 Vaccine oramed.com ↗ |
| 2021-03-23 |
Oramed, Ltd. |
Oramed Initiates Second Phase 3 Oral Insulin Study Under the FDA’s Approved Dual Concurrent Protocol oramed.com ↗ |
| 2021-03-16 |
Oramed, Ltd. |
Oramed Reaches 25% Randomization in World’s First Phase 3 Oral Insulin Study Conducted Under FDA Approved Protocol oramed.com ↗ |
| 2021-01-21 |
Oramed, Ltd. |
Oramed Doses Patients Across Multiple Sites in Phase 3 Oral Insulin Study oramed.com ↗ |
| 2020-12-02 |
Oramed, Ltd. |
Oramed Initiates Phase 2 NASH Trial of Oral Insulin oramed.com ↗ |
| 2020-11-24 |
Oramed, Ltd. |
Oramed Initiates Phase 3 Trial of Oral Insulin oramed.com ↗ |
| 2020-10-28 |
Oramed, Ltd. |
Oramed to Present Phase 2b Oral Insulin Data at American Association of Pharmaceutical Scientists 2020 PharmSci 360 Conference oramed.com ↗ |
| 2020-10-27 |
Oramed, Ltd. |
Oramed CEO Nadav Kidron & Premas Biotech to Host Webinar “The Journey of Oral Insulin: Oramed Story” on Wednesday October 28, 2020 oramed.com ↗ |
| 2020-10-16 |
Oramed, Ltd. |
Oramed Issues Shareholder Update on Pivotal Phase 3 Oral Insulin Studies: Protocols Submitted to FDA oramed.com ↗ |
| 2020-09-15 |
Oramed, Ltd. |
Oramed’s Diabetes Market Survey Shows Strong Support for ORMD-0801 Oral Insulin Among Physicians and Patients oramed.com ↗ |
| 2020-07-15 |
Oramed, Ltd. |
Oramed Reports Positive End of Phase 2 Meeting With the FDA for Oral Insulin oramed.com ↗ |
| 2020-06-15 |
Oramed, Ltd. |
Oramed Announces Positive Initial Clinical Trial Results for Treatment of NASH With Oral Insulin oramed.com ↗ |
| 2020-03-19 |
Oramed, Ltd. |
Oramed Receives Positive Feedback From End-of-Phase 2 Oral Insulin CMC Meeting With FDA oramed.com ↗ |
| 2020-02-26 |
Oramed, Ltd. |
Oramed Reports Positive Results in the Final Cohort of Its Phase 2b Oral Insulin Trial oramed.com ↗ |
| 2019-11-19 |
Oramed, Ltd. |
Oramed Provides Highlights and Data From Its Phase IIb Oral Insulin Study Investor Event oramed.com ↗ |
| 2019-11-12 |
Oramed, Ltd. |
Oramed Announces Successful Phase IIb Study of Oral Insulin in Type 2 Diabetes oramed.com ↗ |
| 2019-09-17 |
Oramed, Ltd. |
Oramed Announces Last Patient Treated in Pivotal Phase IIb Trial of Oral Insulin ORMD-0801 oramed.com ↗ |
| 2019-05-21 |
Oramed, Ltd. |
Oramed Completes Patient Recruitment of Phase IIb HbA1c Trial for Oral Insulin Capsule ORMD-0801 oramed.com ↗ |
| 2019-03-26 |
Oramed, Ltd. |
Chinese Regulatory Authority [NMPA] Approves IND Application of Oramed’s Oral Insulin Capsules oramed.com ↗ |
| 2018-10-04 |
Oramed, Ltd. |
Oramed Enrolls First Patient in Its Clinical Study for Oral Insulin in the Treatment of NASH oramed.com ↗ |
| 2018-06-25 |
Oramed, Ltd. |
Oramed Enrolls First Patient in Its Glucose Clamp Study for Oral Insulin oramed.com ↗ |
| 2018-06-21 |
Oramed, Ltd. |
Oramed Initiates Food Effect Study for Its Oral Insulin Capsule ORMD-0801 oramed.com ↗ |
| 2018-05-16 |
Oramed, Ltd. |
First Oral Insulin For Diabetics Takes Major Step Towards FDA Approval oramed.com ↗ |
| 2018-04-23 |
Oramed, Ltd. |
Oramed Initiates Its 90-Day Pivotal Dose-Ranging Clinical Study for Oral Insulin oramed.com ↗ |
| 2017-11-14 |
Oramed, Ltd. |
Oramed Receives Regulatory Approval to Conduct Clinical Study for Treatment of NASH with its Oral Insulin Capsule oramed.com ↗ |
| 2017-09-05 |
Oramed, Ltd. |
Oramed Announces Successful Meeting with FDA for Oral Insulin oramed.com ↗ |
| 2017-04-20 |
Oramed, Ltd. |
Oramed Granted European Patent for Combination Oral Insulin and GLP-1 Analog Capsule oramed.com ↗ |
|